Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
All content for TGen Talks is the property of TGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
Episode 72: Fowl Play: Viewing the New Strain of Bird Flu Through a Genomic Lens
TGen Talks
19 minutes 17 seconds
1 year ago
Episode 72: Fowl Play: Viewing the New Strain of Bird Flu Through a Genomic Lens
On this month’s TGen Talks, David Engelthaler, Ph.D., professor and director of TGen’s Pathogen and Microbiome Division, discusses the recent surge of bird flu, also known as H5N1.
H5N1 has been in the news a lot lately, but what does it all mean? Engelthaler breaks down the science and talks about the effects this particular strain might have on humans. He also explains what constitutes an outbreak, how they fade over time, and why they start anew.
Bird flu, like other influenza viruses, changes and mutates over time, and the H5N1 strain is particularly concerning. Although it is currently a low risk for human outbreak (there are only 3 known cases in the U.S. thus far), its impact on other animals, especially poultry and cattle, caught the attention of the CDC, USDA and other groups that monitor such outbreaks.
Engelthaler notes that outbreaks are often first noticed by wildlife managers or at zoos, where bird die-offs prompt testing for influenza. Over the past two years, the current bird flu strain has spread significantly by wild birds across North America and the rest of the world.
The good news: In Arizona, only one mammal, an Abert’s tree squirrel, has tested positive for H5N1 to date. TGen researchers are working with local wildlife and health officials to monitor the situation.
TGen Talks
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.